123 related articles for article (PubMed ID: 12383866)
1. Substance P (NK(1)) receptor expression by human colonic epithelial cell line Caco-2.
Böckmann S
Peptides; 2002 Oct; 23(10):1783-91. PubMed ID: 12383866
[TBL] [Abstract][Full Text] [Related]
2. Neurokinin-1 receptor (NK-1R) expression is induced in human colonic epithelial cells by proinflammatory cytokines and mediates proliferation in response to substance P.
Goode T; O'Connor T; Hopkins A; Moriarty D; O'Sullivan GC; Collins JK; O'Donoghue D; Baird AW; O'Connell J; Shanahan F
J Cell Physiol; 2003 Oct; 197(1):30-41. PubMed ID: 12942538
[TBL] [Abstract][Full Text] [Related]
3. Substance P-induced mitogenesis in human astrocytoma cells correlates with activation of the mitogen-activated protein kinase signaling pathway.
Luo W; Sharif TR; Sharif M
Cancer Res; 1996 Nov; 56(21):4983-91. PubMed ID: 8895754
[TBL] [Abstract][Full Text] [Related]
4. Neurokinin 1 and 2 receptors mediate cholera toxin secretion in rat jejunum.
Turvill JL; Connor P; Farthing MJ
Gastroenterology; 2000 Oct; 119(4):1037-44. PubMed ID: 11040190
[TBL] [Abstract][Full Text] [Related]
5. Role of nitric oxide and septide-insensitive NK(1) receptors in bronchoconstriction induced by aerosolised neurokinin A in guinea-pigs.
Ricciardolo FL; Trevisani M; Geppetti P; Nadel JA; Amadesi S; Bertrand C
Br J Pharmacol; 2000 Mar; 129(5):915-20. PubMed ID: 10696090
[TBL] [Abstract][Full Text] [Related]
6. Substance P-induced cyclooxygenase-2 expression in human umbilical vein endothelial cells.
Gallicchio M; Rosa AC; Benetti E; Collino M; Dianzani C; Fantozzi R
Br J Pharmacol; 2006 Mar; 147(6):681-9. PubMed ID: 16432508
[TBL] [Abstract][Full Text] [Related]
7. The NK-1 receptor is expressed in human primary gastric and colon adenocarcinomas and is involved in the antitumor action of L-733,060 and the mitogenic action of substance P on human gastrointestinal cancer cell lines.
Rosso M; Robles-Frías MJ; Coveñas R; Salinas-Martín MV; Muñoz M
Tumour Biol; 2008; 29(4):245-54. PubMed ID: 18781096
[TBL] [Abstract][Full Text] [Related]
8. Metalloproteinases and transforming growth factor-alpha mediate substance P-induced mitogen-activated protein kinase activation and proliferation in human colonocytes.
Koon HW; Zhao D; Na X; Moyer MP; Pothoulakis C
J Biol Chem; 2004 Oct; 279(44):45519-27. PubMed ID: 15319441
[TBL] [Abstract][Full Text] [Related]
9. Substance P induces expression of the corticotropin-releasing factor receptor 1 by activation of the neurokinin-1 receptor.
Hamke M; Herpfer I; Lieb K; Wandelt C; Fiebich BL
Brain Res; 2006 Aug; 1102(1):135-44. PubMed ID: 16806114
[TBL] [Abstract][Full Text] [Related]
10. Substance P stimulates cyclooxygenase-2 and prostaglandin E2 expression through JAK-STAT activation in human colonic epithelial cells.
Koon HW; Zhao D; Zhan Y; Rhee SH; Moyer MP; Pothoulakis C
J Immunol; 2006 Apr; 176(8):5050-9. PubMed ID: 16585602
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacological profile of sendide, a tachykinin NK-1 receptor antagonist].
Kisara K; Tan-No K; Sakurada T
Nihon Yakurigaku Zasshi; 1997 Dec; 110(6):315-24. PubMed ID: 9503389
[TBL] [Abstract][Full Text] [Related]
12. Substance P Receptor Antagonist Suppresses Inflammatory Cytokine Expression in Human Disc Cells.
Kepler CK; Markova DZ; Koerner JD; Mendelis J; Chen CM; Vaccaro AR; Risbud MV; Albert TJ; Anderson DG
Spine (Phila Pa 1976); 2015 Aug; 40(16):1261-9. PubMed ID: 25929203
[TBL] [Abstract][Full Text] [Related]
13. Substance P-stimulated interleukin-8 expression in human colonic epithelial cells involves Rho family small GTPases.
Zhao D; Kuhnt-Moore S; Zeng H; Pan A; Wu JS; Simeonidis S; Moyer MP; Pothoulakis C
Biochem J; 2002 Dec; 368(Pt 2):665-72. PubMed ID: 12169092
[TBL] [Abstract][Full Text] [Related]
14. NK1 receptor-mediated endothelium-dependent relaxation and contraction with different sensitivity to post-receptor signaling in pulmonary arteries.
Miike T; Shirahase H; Kanda M; Kunishiro K; Kurahashi K
Vascul Pharmacol; 2009; 51(2-3):147-53. PubMed ID: 19539781
[TBL] [Abstract][Full Text] [Related]
15. Substance P modulates localized calcium transients and membrane current responses in murine colonic myocytes.
Bayguinov O; Hagen B; Sanders KM
Br J Pharmacol; 2003 Apr; 138(7):1233-43. PubMed ID: 12711623
[TBL] [Abstract][Full Text] [Related]
16. Effect of melatonin on the vasopressin secretion as influenced by tachykinin NK-1 receptor agonist and antagonist: in vivo and in vitro studies.
Juszczak M; Boczek-Leszczyk E; Stempniak B
J Physiol Pharmacol; 2007 Dec; 58(4):829-43. PubMed ID: 18195491
[TBL] [Abstract][Full Text] [Related]
17. Oxytocin release from the rat neurohypophysis into the blood: effects of tachykinin NK-1 and NK-2 receptors agonists and antagonists.
Juszczak M; Boczek-Leszczyk E
J Physiol Pharmacol; 2008 Sep; 59(3):553-62. PubMed ID: 18953097
[TBL] [Abstract][Full Text] [Related]
18. Substance P inhibits natural killer cell cytotoxicity through the neurokinin-1 receptor.
Monaco-Shawver L; Schwartz L; Tuluc F; Guo CJ; Lai JP; Gunnam SM; Kilpatrick LE; Banerjee PP; Douglas SD; Orange JS
J Leukoc Biol; 2011 Jan; 89(1):113-25. PubMed ID: 20940324
[TBL] [Abstract][Full Text] [Related]
19. The antiproliferative action of [D-Arg(1), D-Phe(5), D-Trp(7,9), LEU(11)] substance P analogue antagonist against small-cell- and non-small-cell lung cancer cells could be due to the pharmacological profile of its tachykinin receptor antagonist.
Munoz M; Recio S; Rosso M; Redondo M; Covenas R
J Physiol Pharmacol; 2015 Jun; 66(3):421-6. PubMed ID: 26084224
[TBL] [Abstract][Full Text] [Related]
20. Substance P differentially stimulates IL-8 synthesis in human corneal epithelial cells.
Tran MT; Lausch RN; Oakes JE
Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3871-7. PubMed ID: 11053288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
